GEODE CAPITAL MANAGEMENT, LLC

Position in DTIL — Precision Biosciences Inc

CIK 1214717 BOSTON, MA

Position in DTIL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,578,995

+$640,263 QoQ

Shares Held

287,090

+27.2% QoQ

Ownership

1.11%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#12

of 78 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,556,460,669 across 523 Biotechnology names. DTIL ranks #284 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,578,995	287,090	+27.2%	Shares	Defined	2026-05-15
2025-12-31	$938,732	225,657	+106.0%	Shares	Defined	2026-02-09
2025-09-30	$604,555	109,521	+40.9%	Shares	Defined	2025-11-12
2025-06-30	$326,389	77,712	+5.5%	Shares	Defined	2025-08-08
2025-03-31	$351,486	73,687	+14.2%	Shares	Defined	2025-05-13
2024-12-31	$245,901	64,541	-2.2%	Shares	Defined	2025-02-12
2024-09-30	$591,126	65,974	+40.7%	Shares	Defined	2024-11-12
2024-06-30	$456,200	46,886	+57.1%	Shares	Defined	2024-08-09
2024-03-31	$404,671	29,843	—	Shares	Defined	2024-05-13
No filing history on record for this holder in this stock.